In a trial on tirzepatide, a once-weekly 15 mg dose resulted in a 20.9% reduction in body weight over 72 weeks compared to a weight reduction of 3.1% in the placebo group
Works well for most adults with average to above-average subcutaneous fat
These are not replacements for the foundational strategies discussed above, but they represent an advanced tier of intervention for people who want to be as proactive as possible about hair preservation during GLP-1 therapy
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Important: if hypoglycaemia occurs while taking acarbose, it must be treated with glucose (dextrose) tablets, not sucrose, as acarbose inhibits sucrose breakdown
You're communicating asynchronously - you send a message, a clinician reviews it, and you get a response